Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model

Eye

Volumn 21, Issue 7, 2007, Pages 990-994

  Yagci R ^a   Oflu, Y ^a   Dincel A ^b   Kaya, E ^a   Yagci S ^b   Bayar, B ^b   Duman, S ^a   Bozkurt, A ^b  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; MOXIFLOXACIN; OFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; DRUG PENETRATION; DRUG TISSUE LEVEL; ENDOPHTHALMITIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INOCULATION; NONHUMAN; RABBIT; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE; VITREOUS BODY;

EID: 34447562795     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702414     Document Type: Article

References (28)

1. Puliafito CA, Baker AS, Haaf J, Foster CS. Infectious endophthalmitis: review of 36 cases. Ophthalmology 1982; 89: 921-929.
2. Shrader SK, Band JD, Lauter CB, Murphy P. The clinical spectrum of endophthalmitis: Incidence, predisposing factors, and features influencing outcome. J Infect Dis 1990; 162: 115-120.
3. Endophthalmitis Vitrectomy Study Group. Results of the endophthalmitis vitrectomy study. A randomized trial of immediate vitrectomy and intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthamol 1995; 113: 1479-1496.
4. Looming JP. Treatment of ocular infections with topical antibacterial. Clin, Pharmacokinet 1999; 37: 351-360.
5. Blondeau JM. Fluoroquinolones: Mechanism of action, classification, and development of resistance. Surv Ophthalmol 2004; 49: 73-78.
6. Hooper DC. Mode of action of fluoroquinolones. Drugs 1999; 58 6-10.
7. Ambrose PG. Owens RC, Quintiliani R, Nightingale CH. New generations of quinolones: With particular attention to levofloxacin. Conn Med 1997; 61: 269-272.
8. Cekic O, Batman C, Yasar U, Basci NE, Bozkurt A, Kayaalp SO. Comparison of aqueous humour and vitreous humour levels of two 0.3% ciprofloxacin eyedrops. Can J Ophthalmol 1998; 33: 373-376.
9. Çekiç O, Batman C, Yaşar U, Basci NE, Bozkurt A, Kayaalp SO. Human aqueous and vitreous humour levels of ciprofloxacin following oral and topical administration. Eye 1999; 13: 555-558.
10. Yalvac IS, Basci NE, Bozkurt A, Duman S. Penetration of topically applied ciprofloxacin and ofloxacin into the aqueous humor and vitreous. J Cataract Refract Surg 2003; 29: 487-491.
11. Yamada M, Mochizuki H, Yamada K, Kawai M, Mashima Y. Aqueous humor levels of topically applied levofloxacin, norfloxacin, and lomefloxacin in the same human eyes. J Cataract Refract Surg 2003; 29: 1771-1775.
12. Solomon R, Donnenfeld ED, Perry HD, Snyder RW, Nedrud C, Stein J et al. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology 2005; 112: 466-469.
13. Hariprasad SM. Blinder KJ, Shah GK,. Apte RS, Rosenblatt B, Holekamp NM et al. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol 20055; 123: 39-44.
14. Ozturk F. Kurt F, Inan UU, Kortunay MC, Ilker SS, Basci NE et al. Penetration of topical and oral ofloxacin into the aqueous and vitreous humor of inflamed rabbit eyes. Int J Pharm 2000; 204: 91-95.
15. Brenner S, Jehl, F, Peter JD, Ploy MC, Renault C, Arvis P et al. Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors. Antimicrob Agents Chemother 2003; 47: 1621-1629.
16. Marangon FB, Miller D, Muallem MS, Romano AC, Alfonso EC. Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis. Am J Ophthalmol 2004; 137: 453-458.
17. Colleaux KM, Hamilton WK. Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery. Can J Ophthalmol 2000; 35: 373-378.
18. Jim LK, el-Sayed N, Al-Khamis KI. A simple high performance liquid chromatographic assay for ciprofloxacin in human serum. J Clin Pharm Ther 1992; 17: 111-115.
19. Basci NE, Bozkurt A, Kalayci D, Kayaalp SO. Rapid liquid chromatographic assay of ciprofloxacin in human aqueous humor. J Pharm Biomed Anal 1996; 14: 353-356.
20. Hwang DG. Fluoroquinollone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol 2004; 49: 79-83.
21. Mah FS. Fourth-generation fluoroquinolones: New topical agents in the war on ocular bacterial infections. Curr Opin Ophthalmol 2004; 15: 316-320.
22. Nagaki Y, Hayasaka S, Kadoi C, Matsumoto M, Yanagisawa S, Watanabe K et al. Bacterial endophthalmitis alter small-incision cataract surgery: Effect of incision placement and intraocular lens type. J Cataract Refract Surg 2003; 29: 20-26.
23. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: New weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 2002; 133: 463-466.
24. Fukuda H, Kishii R, Takei M, Hayashi K, Hosaka M. Contributions of the 8-methoxy group of gatifloxacin to resistance selectivity, target preference, and antibacterial activity against Streptococcus pneumoniae. Antimicrob Agents Chemother 2001; 45: 1649-1653.
25. Kattan HM, Flynn Jr HW, Pflugfelder SC, Robertson C, Forster RK. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology 1991; 98: 227-218.
26. Colleaux KM, Hamilton WK. Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery. Can J Ophthalmol 2000; 35: 373-378.
27. Kirsch LS, Jackson WB, Goldstein DA, Discepola MJ. Perioperative ofloxacin vs tobramycin: Efficacy in external ocular adnexal sterilization and anterior chamber penetration. Can J Ophthalmol 1995; 30: 11-20.
28. Price Jr FW, Dobbins K, Zeh W. Penetration of topically administered ofloxacin and trimethoprim into aqueous humor. J Ocul Pharmacol Ther 2002; 18: 445-453.